I am/have/had
I am looking for
Advanced Filters
Found 11061 clinical trials
CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children
Relapsed acute lymphoblastic leukaemia (ALL) has a poorer outcome than newly diagnosed ALL patients with only about 40% overall survival after re-treatment. The study CCCG Relapsed ALL 2017 study will adopt the UK R3 study stratification and treatment backbone with two new agents added.
b-cell acute lymphoblastic leukemia
rituximab
testicular
proteasome inhibitor
leukemic cells
- 0 views
- 19 Feb, 2024